The Commercial Aquaculture Vaccines Market To Line Up With The Technological Up

Posted by Ashish on April 8th, 2021

Increasing risk of transmission of pathogens from animal food is expected surge demand for commercial aquaculture vaccines. According to the Food and Agriculture Organization (FAO) of the United Nations 2020, aquaculture accounted for around 46 percent of total food production and 52 percent of fish for human consumption. Besides, aquatic species farming is one of the fastest-growing food sectors, globally. Commercial aquaculture vaccines are projected to gain traction due to shift of the aquaculture industry toward preventive vaccinations from conventional antibiotic treatments, due to increased risk of dissemination. According to the Global Aquaculture Alliance, Chilean salmon farmers have cut antibiotic usage substantially over the last three years.

An increase in global consumption and production of aquatic species exhibits exponential growth potential for the commercial aquaculture vaccines market. Additionally, increased prevalence of bacterial and zoonotic infections among aquaculture species has been observed, which has widened market opportunities.

The COVID-19 pandemic has changed animal healthcare priorities and spending, but this is considered to be a short-term negative impact on the vaccines market. Disruptions in supply chain across the global fish aquaculture industry and rising awareness of animal to human pathogen transmission risks are expected to slow down the market in the short term.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32289

Companies covered in Commercial Aquaculture Vaccines Market Report

  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Canada inc
  • HIPRA
  • Elanco
  • AQUATRECK ANIMAL HEALTH S.L.
  • MSD Animal Health
  • Zoetis LLC
  • Centrovet Laboratories inc.
  • Intervet-International BV

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author